Substance use disorders and risk of severe maternal morbidity in the United States

Admon, 2017, Disparities in chronic conditions among women hospitalized for delivery in the United States, 2005-2014, Obstet. Gynecol., 130, 1319, 10.1097/AOG.0000000000002357 Admon, 2018, Amphetamine- and opioid-affected births: incidence, outcomes, and costs, United States, 2004-2015, Am. J. Public Health, e1 Admon, 2018, Racial and ethnic disparities in the incidence of severe maternal morbidity in the United States, 2012-2015, Obstet. Gynecol., 132, 1158, 10.1097/AOG.0000000000002937 Alkema, 2016, Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group, Lancet, 387, 462, 10.1016/S0140-6736(15)00838-7 Andersson, 2018, Epidemiology of cardiovascular disease in young individuals, Nat. Rev. Cardiol., 15, 230, 10.1038/nrcardio.2017.154 Aoyama, 2019, Association of maternal age with severe maternal morbidity and mortality in Canada, JAMA Netw. Open, 2, 10.1001/jamanetworkopen.2019.9875 Atkinson, 2015, Risk factors for perinatal mortality in patients admitted to the hospital with the diagnosis of placental abruption, J. Matern. Fetal. Neonatal. Med., 28, 594, 10.3109/14767058.2014.927427 Behnke, 2013, Prenatal substance abuse: short- and long-term effects on the exposed fetus, Pediatrics, 131, e1009, 10.1542/peds.2012-3931 Centers for Disease Control and Prevention, 2015 Centers for Disease, C., Prevention, 2012, Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services, MMWR Recomm. Rep., 61, 1 Cohen, 2017, Placental complications associated with psychostimulant use in pregnancy, Obstet. Gynecol., 130, 1192, 10.1097/AOG.0000000000002362 Creanga, 2014, Maternal mortality and morbidity in the United States: where are we now?, J. Womens Health (Larchmt), 23, 3, 10.1089/jwh.2013.4617 El Marroun, 2009, Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study, J. Am. Acad. Child Adolesc. Psychiatry, 48, 1173, 10.1097/CHI.0b013e3181bfa8ee Fingar, 2018 Haight, 2018, Opioid use disorder documented at delivery hospitalization - United States, 1999-2014, MMWR Morb. Mortal. Wkly. Rep., 67, 845, 10.15585/mmwr.mm6731a1 Healthcare Cost and Utilization Project, 2015, HCUP methods series: missing data methods for the NIS and the SID Healthcare Cost and Utilization Project, 2019 Hernandez-Avila, 2004, Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment, Drug Alcohol Depend., 74, 265, 10.1016/j.drugalcdep.2004.02.001 Himes, 2020, Validation of criteria to identify severe maternal morbidity, Paediatr. Perinat. Epidemiol., 10.1111/ppe.12610 Hser, 2012, Mortality among substance-using mothers in California: a 10-year prospective study, Addiction, 107, 215, 10.1111/j.1360-0443.2011.03613.x Ingram, 2014, 2013 NCHS urban-rural classification scheme for counties, Vital Health Stat, 2, 1 Janevic, 2020, Neighborhood racial and economic polarization, hospital of delivery, and severe maternal morbidity, Health Aff. (Millwood), 39, 768, 10.1377/hlthaff.2019.00735 Jarlenski, 2020, Polysubstance use among pregnant women with opioid use disorder in the United States, 2007-2016, Obstet. Gynecol., 10.1097/AOG.0000000000003907 Jenkins, 2015, Substance use disorder prevention and treatment in stigmatized patient populations: ripe for innovation, Subst. Abus., 36, 1, 10.1080/08897077.2015.1009266 Jones, 2012, Maternal opioid treatment: human experimental research (MOTHER)--approach, issues and lessons learned, Addiction, 107, 28, 10.1111/j.1360-0443.2012.04036.x Kozhimannil, 2019, Rural-urban differences in severe maternal morbidity and mortality in the US, 2007-15, Health Aff. (Millwood), 38, 2077, 10.1377/hlthaff.2019.00805 Krans, 2019, Medication-assisted treatment use among pregnant women with opioid use disorder, Obstet. Gynecol., 133, 943, 10.1097/AOG.0000000000003231 Kuklina, 2010, Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004-2006, Obstet. Gynecol., 115, 93, 10.1097/AOG.0b013e3181c4ee8c Kuklina, 2011, Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006, BJOG, 118, 345, 10.1111/j.1471-0528.2010.02743.x Kuklina, 2008, An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity, Matern. Child Health J., 12, 469, 10.1007/s10995-007-0256-6 Kuklina, 2009, Severe obstetric morbidity in the United States: 1998-2005, Obstet. Gynecol., 113, 293, 10.1097/AOG.0b013e3181954e5b Lash, 2007, Heuristic thinking and inference from observational epidemiology, Epidemiology, 18, 67, 10.1097/01.ede.0000249522.75868.16 Lisonkova, 2017, Maternal age and severe maternal morbidity: a population-based retrospective cohort study, PLoS Med., 14, 10.1371/journal.pmed.1002307 Main, 2015, National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage, Anesth. Analg., 121, 142, 10.1097/AOG.0000000000000869 Main, 2016, Measuring severe maternal morbidity: validation of potential measures, Am. J. Obstet. Gynecol., 214, e641 McGrew, 2020, Validity of International Classification of Diseases codes in identifying illicit drug use target conditions using medical record data as a reference standard: a systematic review, Drug Alcohol Depend., 208, 10.1016/j.drugalcdep.2019.107825 Metz, 2015, Marijuana use in pregnancy and lactation: a review of the evidence, Am. J. Obstet. Gynecol., 213, 761, 10.1016/j.ajog.2015.05.025 Metz, 2017, Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity, Am. J. Obstet. Gynecol. National Academy of Medicine Committee on the Health Effects of Marijuana, 2017 National Institute on Drug Abuse, 2020 Say, 2009, Maternal near miss--towards a standard tool for monitoring quality of maternal health care, Best Pract. Res. Clin. Obstet. Gynaecol., 23, 287, 10.1016/j.bpobgyn.2009.01.007 Smid, 2019, Stimulant use in pregnancy: an under-recognized epidemic among pregnant women, Clin. Obstet. Gynecol., 62, 168, 10.1097/GRF.0000000000000418 Substance Abuse and Mental Health Services Administration, 2014 Terplan, 2015, Prenatal substance use: exploring assumptions of maternal unfitness, Subst. Abuse, 9, 1 Wang, 2020, Social determinants of pregnancy-related mortality and morbidity in the United States: a systematic review, Obstet. Gynecol., 135, 896, 10.1097/AOG.0000000000003762 Wolfe, 2005, Mortality risk associated with perinatal drug and alcohol use in California, J. Perinatol., 25, 93, 10.1038/sj.jp.7211214 Young-Wolff, 2017, Trends in self-reported and biochemically tested marijuana use among pregnant females in California From 2009-2016, JAMA, 318, 2490, 10.1001/jama.2017.17225 Zedler, 2016, Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child, Addiction, 111, 2115, 10.1111/add.13462